World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

MANAGING REFRACTORY DEPRESSION WITH KETAMINE AND NITROUS OXIDE

Dr. Muhammad Usman Faisal*, Dr. Imran Khan and Dr. Muhammad Aamir Javed

ABSTRACT

Major depression is a serious health problem that affects children, adolescents, adults and the elderly, most often in females. Traditional antidepressants have a high rate of therapeutic failure, with suicide being frequent during the beginning of treatment. This study was conducted in Allied hospital Faisalabad. Ketamine administered by diverse routes in sub-anesthetic doses and the inhalation of nitrous oxide have shown a sharp reduction of the indicators of major depression. The molecular mechanisms of action of these general México anesthetics have been very controversial and most of the studies involve the NMDA receptor, although there is new evidence pointing to non- NMDA receptors as an important part of the rapid antidepressant effects of ketamine. Ketamine (intravenous, nasal, sublingual, oral, intramuscular, subcutaneous) results in a rapid and effective treatment for depression with few side effects. It is most frequently given as 0.5 mg/kg intravenous infusion, and the results are perceived few hours after its administration, lasting up to 2 weeks. Future knowledge of the underlying molecular mechanisms, the therapeutic results and the immediate and long-term side effects of ketamine and nitrous oxide guarantee the development.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR